multiple sclerosis

Intraspinal implant of mesenchymal stem cells may not heal demyelinated spinal cord

harminka — Thu, 13 Nov 2008 09:01:09 -0600

Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord. Therapeutic hope for curing multiple sclerosis and other demyelinating diseases has included the possibility that stem cell transplants could help remyelinate the spinal cord.

Multiple sclerosis progression can be predicted with MRI

harminka — Thu, 06 Nov 2008 07:04:50 -0600

A new study published in Journal of Neuroimaging shows that MRI scans used on multiple sclerosis (MS) patients to determine if the disease has affected gray matter in the brain can identify those at-risk for progression of disability.

Multiple sclerosis research charges ahead with new mouse model of disease

harminka — Thu, 06 Nov 2008 06:28:02 -0600

A new study highlights the role of a charge-switching enzyme in nervous system deficits characteristic of multiple sclerosis and other related neurological illness.

Interferon could be key to preventing or treating multiple sclerosis

harminka — Thu, 30 Oct 2008 14:49:59 -0500

Multiple sclerosis (MS) results when the body's own defense system attacks nerve fibers in the brain and spinal cord. Now scientists led by John Russell, Ph.D., at Washington University School of Medicine in St. Louis have shown that interferon-gamma plays a deciding role in whether immune cells attack and injure the central nervous system (brain and spinal cord) in mice.

BG-12 significantly reduced brain lesions in multiple sclerosis

harminka — Fri, 24 Oct 2008 08:05:05 -0500

Biogen Idec (NASDAQ: BIIB) today announced the publication of Phase IIb data showing that a 240 mg three-times-daily dose of the company's novel oral compound, BG-12 (BG00012, dimethyl fumarate), reduced the number of new gadolinium enhancing (Gd+) lesions by 69 percent in patients with relapsing-remitting multiple sclerosis (MS) when compared to treatment with placebo (p<0.0001).

New hope for multiple sclerosis sufferers

harminka — Thu, 23 Oct 2008 10:06:27 -0500

esearch indicates drug not only stops the disease from advancing but may also restore lost function in many patients

Response to immune protein determines pathology of multiple sclerosis

harminka — Mon, 13 Oct 2008 08:24:48 -0500

New research may help reveal why different parts of the brain can come under attack in patients with multiple sclerosis (MS). According to a new study in mice with an MS-like disease, the brain's response to a protein produced by invading T cells dictates whether it's the spinal cord or cerebellum that comes under fire.

Multiple sclerosis patients have higher spinal fluid levels of suspicious immune molecule

harminka — Tue, 30 Sep 2008 08:19:10 -0500

A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease.

Children vaccinated against hepatitis B not at increased risk of MS

harminka — Fri, 26 Sep 2008 07:11:27 -0500

The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS), according to a study to be published in the October 8, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Despite Risks, Powerful Drugs Offer Hope and Relief to Autoimmune Patients

gstone — Mon, 11 Aug 2008 09:04:53 -0500

New Survey by Applied Data Research Analyzes Therapeutic and Commercial Factors in Treating Autoimmune Diseases

Pen Injectors Becoming Dominant Force in Many Therapeutic Sectors

mksmith — Mon, 04 Aug 2008 09:21:50 -0500

Greystone Associates Assessment Identifies a Number of Therapy Areas Where Pens are Achieving Double-Digit Growth

Early diagnosis of Multiple Sclerosis in animal model

harminka — Sat, 02 Aug 2008 05:34:06 -0500

In an animal model of multiple sclerosis (MS), neuroradiologists and neurologists of the University hospitals of Heidelberg and Würzburg have been able to visualize inflammatory tissue damage, most of which had remained unrecognized up to now, with the aid of a new contrast medium, Gadofluorine M, in magnetic resonance imaging.